InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Browse the full record of transactions filed by Utter Christine Marie, Chief Financial Officer. Officer active across 1 company, notably PTC Therapeutics, INC.. Aggregated, 6 filings have been published. Split: 0 buy · 6 sells. Total volume traded: €182k. History available since 7 January 2022. The latest transaction was disclosed on 1 February 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations6 total
313 shares@ US$40.0020.0002% mcap12.2% of flowCommon StockSEC:0001179110-22-000841
313 shares@ US$40.0020.0002% mcap6.1% of flowCommon StockSEC:0001179110-22-000841:0
1,428 shares@ US$43.500.0009% mcap59.8% of flowCommon StockSEC:0001104659-22-005976
1,428 shares@ US$43.500.0009% mcap29.9% of flowCommon StockSEC:0001104659-22-005976:0
747 shares@ US$38.5250.0004% mcap14.0% of flowCommon StockSEC:0001179110-22-000401:0
747 shares@ US$38.5250.0004% mcap28.0% of flowCommon StockSEC:0001179110-22-000401
6 of 6 declarations
About Utter Christine Marie
Christine Marie Utter is the Chief Financial Officer and Chief Administrative Officer at PTC Therapeutics, Inc. She oversees financial management and administrative operations of the company. Her role is essential in ensuring compliance and operational efficiency at PTC Therapeutics.
